175 related articles for article (PubMed ID: 16173257)
1. Interstitial lung disease due to polymyositis or dermatomyositis: effect of a 6-month course of i.v. pulse cyclophosphamide.
Meyer O; Hayem G; Palazzo E; Crestani B; Debray MP; Ballard M
Clin Exp Rheumatol; 2005; 23(5):724. PubMed ID: 16173257
[No Abstract] [Full Text] [Related]
2. Interstitial lung disease in polymyositis and dermatomyositis: clinical course and response to treatment.
Schnabel A; Reuter M; Biederer J; Richter C; Gross WL
Semin Arthritis Rheum; 2003 Apr; 32(5):273-84. PubMed ID: 12701038
[TBL] [Abstract][Full Text] [Related]
3. Intravenous cyclophosphamide therapy for progressive interstitial pneumonia in patients with polymyositis/dermatomyositis.
Yamasaki Y; Yamada H; Yamasaki M; Ohkubo M; Azuma K; Matsuoka S; Kurihara Y; Osada H; Satoh M; Ozaki S
Rheumatology (Oxford); 2007 Jan; 46(1):124-30. PubMed ID: 16754626
[TBL] [Abstract][Full Text] [Related]
4. Successful combined therapy of cyclophosphamide and cyclosporine for acute exacerbated interstitial pneumonia associated with dermatomyositis.
Tanaka F; Origuchi T; Migita K; Tominaga M; Kawakami A; Kawabe Y; Eguchi K
Intern Med; 2000 May; 39(5):428-30. PubMed ID: 10830189
[TBL] [Abstract][Full Text] [Related]
5. Pulse intravenous cyclophosphamide treatment for steroid-resistant interstitial pneumonitis associated with polymyositis.
Yoshida T; Koga H; Saitoh F; Sakamoto M; Harada M; Yoshida H; Sakisaka S; Sata M
Intern Med; 1999 Sep; 38(9):733-8. PubMed ID: 10480306
[TBL] [Abstract][Full Text] [Related]
6. Favorable outcomes with tacrolimus in two patients with refractory interstitial lung disease associated with polymyositis/dermatomyositis.
Ochi S; Nanki T; Takada K; Suzuki F; Komano Y; Kubota T; Miyasaka N
Clin Exp Rheumatol; 2005; 23(5):707-10. PubMed ID: 16173253
[TBL] [Abstract][Full Text] [Related]
7. [Pulmonary damage during polymyositis and dermatomyositis: interstitial lung disease].
Marie I; Dominique S
Presse Med; 2006 Apr; 35(4 Pt 2):683-95. PubMed ID: 16614615
[TBL] [Abstract][Full Text] [Related]
8. Comment on: The efficacy of tacrolimus in patients with interstitial lung diseases complicated with polymyositis or dermatomyositis.
Nagashima T; Minota S
Rheumatology (Oxford); 2015 Jun; 54(6):1128-9. PubMed ID: 25832615
[No Abstract] [Full Text] [Related]
9. Comment on: The efficacy of tacrolimus in patients with interstitial lung diseases complicated with polymyositis or dermatomyositis: reply.
Yasuda S; Kurita T; Horita T; Atsumi T
Rheumatology (Oxford); 2015 Jun; 54(6):1129. PubMed ID: 25832614
[No Abstract] [Full Text] [Related]
10. A retrospective review of clinical features and treatment outcomes in steroid-resistant interstitial lung disease from polymyositis/dermatomyositis.
Mira-Avendano IC; Parambil JG; Yadav R; Arrossi V; Xu M; Chapman JT; Culver DA
Respir Med; 2013 Jun; 107(6):890-6. PubMed ID: 23517887
[TBL] [Abstract][Full Text] [Related]
11. The efficacy of tacrolimus in patients with interstitial lung diseases complicated with polymyositis or dermatomyositis.
Kurita T; Yasuda S; Oba K; Odani T; Kono M; Otomo K; Fujieda Y; Oku K; Bohgaki T; Amengual O; Horita T; Atsumi T
Rheumatology (Oxford); 2015 Jan; 54(1):39-44. PubMed ID: 24764266
[TBL] [Abstract][Full Text] [Related]
12. Cyclosporine treatment for polymyositis/dermatomyositis: is it possible to rescue the deteriorating cases with interstitial pneumonitis?
Maeda K; Kimura R; Komuta K; Igarashi T
Scand J Rheumatol; 1997; 26(1):24-9. PubMed ID: 9057798
[TBL] [Abstract][Full Text] [Related]
13. [Treatment of steroid-resistant polymyositis and dermatomyositis].
Mimura T; Kanda H; Kubo K
Nihon Rinsho; 2001 Oct; 59(10):2062-70. PubMed ID: 11676154
[TBL] [Abstract][Full Text] [Related]
14. [Coping with pathological changes in heart and lung in collagen diseases--dermatomyositis and interstitial pneumonia].
Nawata Y
Nihon Naika Gakkai Zasshi; 1996 Nov; 85(11):1850-4. PubMed ID: 9019505
[No Abstract] [Full Text] [Related]
15. Effective Use of Calcineurin Inhibitor in Combination Therapy for Interstitial Lung Disease in Patients With Dermatomyositis and Polymyositis.
Shimojima Y; Ishii W; Matsuda M; Kishida D; Ikeda SI
J Clin Rheumatol; 2017 Mar; 23(2):87-93. PubMed ID: 28225510
[TBL] [Abstract][Full Text] [Related]
16. Interstitial lung disease in polymyositis and dermatomyositis.
Schnabel A; Hellmich B; Gross WL
Curr Rheumatol Rep; 2005 Apr; 7(2):99-105. PubMed ID: 15760588
[TBL] [Abstract][Full Text] [Related]
17. [Interstitial lung diseases in polymyositis and dermatomyositis].
Marie I; Dominique S; Rémy-Jardin M; Hatron PY; Hachulla E
Rev Med Interne; 2001 Nov; 22(11):1083-96. PubMed ID: 11817120
[TBL] [Abstract][Full Text] [Related]
18. Cyclophosphamide pulse therapy for rapidly progressive interstitial pneumonia in dermatomyositis. A new possibility for rescue?
Takizawa H; Ito K
Intern Med; 1997 Jul; 36(7):448-9. PubMed ID: 9240490
[No Abstract] [Full Text] [Related]
19. Cutaneous amyloidosis associated with amyopathic dermatomyositis.
Taniguchi Y; Horino T; Terada Y
J Rheumatol; 2009 May; 36(5):1088-9. PubMed ID: 19435977
[No Abstract] [Full Text] [Related]
20. Tacrolimus in idiopathic inflammatory myopathy-associated interstitial lung disease: defining roles and responders.
Gordon P; Gooptu B
Rheumatology (Oxford); 2015 Jan; 54(1):3-4. PubMed ID: 25342374
[No Abstract] [Full Text] [Related]
[Next] [New Search]
